142 related articles for article (PubMed ID: 9354456)
41. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
42. Mmip-2/Rnf-17 enhances c-Myc function and regulates some target genes in common with glucocorticoid hormones.
Yin XY; Grove LE; Prochownik EV
Oncogene; 2001 May; 20(23):2908-17. PubMed ID: 11420703
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
Liu MY; Poellinger L; Walker CL
Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
[TBL] [Abstract][Full Text] [Related]
44. Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest.
Hung KS; Hong CY; Lee J; Lin SK; Huang SC; Wang TM; Tse V; Sliverberg GD; Weng SC; Hsiao M
Biochem Biophys Res Commun; 2000 Mar; 269(3):718-25. PubMed ID: 10720483
[TBL] [Abstract][Full Text] [Related]
45. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
46. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors.
Chernova OB; Somerville RP; Cowell JK
Oncogene; 1998 Dec; 17(22):2873-81. PubMed ID: 9879993
[TBL] [Abstract][Full Text] [Related]
47. c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
Sedoris KC; Thomas SD; Miller DM
Biochemistry; 2007 Jul; 46(29):8659-68. PubMed ID: 17595061
[TBL] [Abstract][Full Text] [Related]
48. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
[TBL] [Abstract][Full Text] [Related]
49. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
50. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
[TBL] [Abstract][Full Text] [Related]
51. Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression.
Manni I; Tunici P; Cirenei N; Albarosa R; Colombo BM; Roz L; Sacchi A; Piaggio G; Finocchiaro G
Br J Cancer; 2002 Feb; 86(3):477-84. PubMed ID: 11875718
[TBL] [Abstract][Full Text] [Related]
52. [Construct Mxi1 mutation gene expression vector from leukemia cell line KG1].
Guo XL; Niu ZY; Zhang GL; Yin FL; Yang L; Ren JH; Dong ZR; Zhu P; Pan L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):498-502. PubMed ID: 22997883
[TBL] [Abstract][Full Text] [Related]
53. Expression, regulation and polymorphism of the mxi1 genes.
Shimizu E; Shirasawa H; Kodama K; Sato T; Simizu B
Gene; 1996 Oct; 176(1-2):45-8. PubMed ID: 8918230
[TBL] [Abstract][Full Text] [Related]
54. Change of MAX interactor 1 expression in an anti-Thy1 nephritis model and its effect on mesangial cell proliferation.
Liu X; Lv Y; Xie Y; Hong Q; Cai G; Zhang S; Liu W; Chen X
Cell Physiol Biochem; 2011; 27(3-4):391-400. PubMed ID: 21471728
[TBL] [Abstract][Full Text] [Related]
55. Mxi1 tumor suppressor gene is not mutated in primary pancreatic adenocarcinoma.
Bartsch D; Peiffer SL; Kaleem Z; Wells SA; Goodfellow PJ
Cancer Lett; 1996 Apr; 102(1-2):73-6. PubMed ID: 8603382
[TBL] [Abstract][Full Text] [Related]
56. Differential expression of c-myc, max and mxi1 in human myeloid leukemia cells during retrodifferentiation and cell death.
Meinhardt G; Hass R
Leuk Res; 1995 Oct; 19(10):699-705. PubMed ID: 7500645
[TBL] [Abstract][Full Text] [Related]
57. Mxi1 is a repressor of the c-Myc promoter and reverses activation by USF.
Lee TC; Ziff EB
J Biol Chem; 1999 Jan; 274(2):595-606. PubMed ID: 9872993
[TBL] [Abstract][Full Text] [Related]
58. Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines.
Wang DY; Xiang YY; Li XJ; Hashimoto M; Tanaka M; Sugimura H
Pathol Int; 2000 May; 50(5):373-83. PubMed ID: 10849326
[TBL] [Abstract][Full Text] [Related]
59. Identification and analysis of tumor suppressor loci at chromosome 10q23.3-10q25.3 in medulloblastoma.
Scott DK; Straughton D; Cole M; Bailey S; Ellison DW; Clifford SC
Cell Cycle; 2006 Oct; 5(20):2381-9. PubMed ID: 17102621
[TBL] [Abstract][Full Text] [Related]
60. Chromosomal localization of the human gene encoding c-myc promoter-binding protein (MPB1) to chromosome 1p35-pter.
White RA; Adkison LR; Dowler LL; Ray RB
Genomics; 1997 Feb; 39(3):406-8. PubMed ID: 9119380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
